Literature DB >> 1658391

Chloroquine induces empty capsid formation during poliovirus eclipse.

P Kronenberger1, R Vrijsen, A Boeyé.   

Abstract

The poliovirus capsid (160S) is modified during eclipse in HeLa cells, which results in at least three types of particles having sedimentation coefficients of 135, 110, and 80S. The lysosomotropic agent chloroquine redirected the production of eclipse products from 135 and 110S particles (containing RNA) to 80S particles (without RNA). The effect started at 5 microM and was fully developed with 20 microM chloroquine. Viral protein synthesis and virion production remained unaffected. The results show that chloroquine can redirect the processing of input virions without interfering with productive uncoating.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658391      PMCID: PMC250817     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  11 in total

1.  Kinetics of poliovirus uncoating in HeLa cells in a nonacidic environment.

Authors:  M Gromeier; K Wetz
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

2.  Eclipse products of poliovirus after cold-synchronized infection of HeLa cells.

Authors:  L Everaert; R Vrijsen; A Boeyé
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

3.  Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily.

Authors:  C L Mendelsohn; E Wimmer; V R Racaniello
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

4.  Poliovirus can enter and infect mammalian cells by way of an intercellular adhesion molecule 1 pathway.

Authors:  H C Selinka; A Zibert; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

5.  Systematic nomenclature of picornavirus proteins.

Authors:  R R Rueckert; E Wimmer
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

6.  Chloroquine enhances replication of Semliki Forest virus and encephalomyocarditis virus in mice.

Authors:  R K Maheshwari; V Srikantan; D Bhartiya
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

7.  Inhibition of Semliki forest virus penetration by lysosomotropic weak bases.

Authors:  A Helenius; M Marsh; J White
Journal:  J Gen Virol       Date:  1982-01       Impact factor: 3.891

8.  Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts.

Authors:  F R Maxfield
Journal:  J Cell Biol       Date:  1982-11       Impact factor: 10.539

9.  Mechanism of entry into the cytosol of poliovirus type 1: requirement for low pH.

Authors:  I H Madshus; S Olsnes; K Sandvig
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

10.  Differentiation of acid-pH-dependent and -nondependent entry pathways for mouse hepatitis virus.

Authors:  C Kooi; M Cervin; R Anderson
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

View more
  17 in total

1.  Uncoating of human rhinovirus serotype 2 from late endosomes.

Authors:  E Prchla; E Kuechler; D Blaas; R Fuchs
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

2.  Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model.

Authors:  Stuart D Dowall; Andrew Bosworth; Robert Watson; Kevin Bewley; Irene Taylor; Emma Rayner; Laura Hunter; Geoff Pearson; Linda Easterbrook; James Pitman; Roger Hewson; Miles W Carroll
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

Review 3.  Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.

Authors:  Anwar M Hashem; Badrah S Alghamdi; Abdullah A Algaissi; Fahad S Alshehri; Abdullah Bukhari; Mohamed A Alfaleh; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2020-05-06       Impact factor: 6.211

Review 4.  Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19.

Authors:  JingKang Sun; YuTing Chen; XiuDe Fan; XiaoYun Wang; QunYing Han; ZhengWen Liu
Journal:  Postgrad Med       Date:  2020-06-21       Impact factor: 3.840

Review 5.  The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway.

Authors:  Frédéric Carrière; Sonia Longhi; Michel Record
Journal:  Biochimie       Date:  2020-05-30       Impact factor: 4.079

6.  New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

Authors:  Christian A Devaux; Jean-Marc Rolain; Philippe Colson; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2020-03-12       Impact factor: 5.283

Review 7.  Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century.

Authors:  Jean-Marc Rolain; Philippe Colson; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2007-07-16       Impact factor: 5.283

Review 8.  Picornavirus inhibitors.

Authors:  L Carrasco
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

9.  Evolution of resistance to fluoroquinolones by dengue virus serotype 4 provides insight into mechanism of action and consequences for viral fitness.

Authors:  Stacey L P Scroggs; Jordan T Gass; Ramesh Chinnasamy; Steven G Widen; Sasha R Azar; Shannan L Rossi; Jeffrey B Arterburn; Nikos Vasilakis; Kathryn A Hanley
Journal:  Virology       Date:  2020-10-01       Impact factor: 3.616

Review 10.  Treatment of COVID 19-Repurposing drugs commonly used in dermatology.

Authors:  Jelena Stojkovic-Filipovic; Martina Bosic
Journal:  Dermatol Ther       Date:  2020-07-16       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.